Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.7B | 7.4B | 6.9B | 7.2B |
Cost of revenue | 5.6B | 5.4B | 4.9B | 5.2B |
Gross profit | 2.1B | 2.0B | 1.9B | 2.0B |
Operating expense | ||||
Research & development | 359.9M | 359.3M | 359.8M | 315.6M |
Selling general and admin | 603.7M | -976.7M | 1.5B | -186.9M |
Other operating expenses | 41.1M | 52.7M | 34.3M | 49.7M |
Operating income | 1.1B | 992.8M | 914.4M | 1.1B |
Non operating interest income | ||||
Income | 21.2M | 27.6M | 17.8M | 42.2M |
Expense | 38.7M | 46.2M | 34.3M | 37.3M |
Other income expense | — | — | — | — |
Pretax income | 1.1B | 939.8M | 897.9M | 1.1B |
Tax provision | 184.6M | 147.6M | 100.0M | 177.6M |
Net income | 923.5M | 792.2M | 797.9M | 875.5M |
Basic EPS | 0.2 | — | — | — |
Diluted EPS | 0.2 | — | — | — |
Basic average shares | 3.8B | — | — | — |
Diluted average shares | 3.8B | — | — | — |
EBITDA | 1.1B | 1.1B | 891.7M | 1.2B |
Net income from continuing op. | — | — | — | — |
Minority interests | -20.1M | 5.0M | -10.4M | -8.7M |
Preferred stock dividends | 0 | 0 | 0 | 0 |